Biocurious: The Cannabis Stocks that Stand Out in a Field of Weeds
6 Articles
6 Articles
The health-political spokesman of the SPD parliamentary group, Pantazis, demands that pain patients can continue to be reliably supplied with medical cannabis.
10 Biggest Cannabis Stocks in the US and Canada
The cannabis market has faced unexpected challenges in 2025, despite initial optimism for rescheduling in the US. While US federal regulatory uncertainty and banking remain persistent, companies are shifting focus to match changes in consumer behavior. The growing popularity of edibles and rising interest in cannabis-infused beverages reflect evolving demand in a persevering industry. Cannabis companies in the sector continue to move forward and…
Biocurious: The cannabis stocks that stand out in a field of weeds
Cannabis suppliers are struggling to differentiate themselves in a commoditised market Regulators have lax telehealth prescribers in their sights Althea Group has sold its medical pot arm in favour of THC-infused beverages Having sprouted in a field of hope and hype eleven years ago, the ASX medicinal cannabis sector has wilted in the face of unrealistic expectations and misguided strategies. Demand isn’t the problem: patients have embraced …
Has Germany’s Medical Cannabis Market Peaked? New Laws, Surging Supply, and Industry Unrest - Cannabis News World
Over the past few years, telemedicine has reshaped how patients access medical cannabis, launching a wave of digital clinics across Europe and beyond. But now, that wave is breaking. In The post Has Germany’s Medical Cannabis Market Peaked? New Laws, Surging Supply, and Industry Unrest appeared first on Business of Cannabis.
Has Germany's Medical Cannabis Market Peaked? New Laws, Surging Supply, and Industry Unrest - Business of Cannabis
Over the past few years, telemedicine has reshaped how patients access medical cannabis, launching a wave of digital clinics across Europe and beyond. But now, that wave is breaking. In this special series, Business of Cannabis investigates the global backlash facing cannabis telehealth. Through the lens of Australia’s prosecutions, Poland’s policy reversal, and Germany’s pending legislation, we explore how telehealth became both a lifeline for …
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium